Commit To Buy Celldex Therapeutics At $3, Earn 23.3% Using Options
November 28, 2016 at 11:43 AM EST
Investors considering a purchase of Celldex Therapeutics, Inc. (CLDX) shares, but cautious about paying the going market price of $4.17/share, might benefit from considering selling puts among the alternative strategies at their disposal..
